Sponsor pipeline

OHSU Knight Cancer Institute clinical trial pipeline

Get alerts when OHSU Knight Cancer Institute's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

Show 1 trial with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-05 NCT07857655 Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head… Phase 4 Recruiting
2026-09-28 NCT07844694 Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder Phase 1 Recruiting

Active trials by phase

Early Phase 1
2
Phase 1
8
Phase 1/2
5
Phase 2
17
Phase 4
4
Not charted: 24 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 30

Leukemia (10) · Prostate Cancer (8) · Acute Myeloid Leukemia (AML) (6) · Pancreatic Cancer (6) · Breast Cancer (5) · Melanoma (5) · Colorectal Cancer (4) · Lung Cancer (4) · Esophageal Cancer (3) · Head & Neck Cancer (3)

Get alerts when OHSU Knight Cancer Institute's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free